Genetic alterations in GBM—such as EGFR amplification or mutation and PTEN deletion—further stabilize HIF-1α through the PI3K/AKT/mTOR pathway, amplifying the hypoxic response. The gene discussed is EGFR; the disease is glioblastoma.